Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity.
Explore this paper's citation graph
Summary
The results suggest that in addition to other monocyte-activating factors, hM-CSF augments monocyte tumoricidal activity against a wide spectrum of tumor targets.
- Type
- article
- Published
- 1989-11-01
- Cited by
- 54
- References
- 32
- OpenAlex
- https://openalex.org/W1941991904
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:14553038
Keywords
Monocyte, Tumor necrosis factor alpha, Lipopolysaccharide, Monokine, Colony-stimulating factor
References
- Hematopoietic colony-stimulating factors.
- Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
- Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
- Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF.
- Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.
- Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism.
- B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
- Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes.
- Effect of antisera against recombinant tumor necrosis factor and the monocyte-derived cytotoxin(s) on monocyte-mediated killing of various tumor cells.
- Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.
- Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes
- Stimulation of macrophage tumoricidal activity by the growth and differentiation factor CSF-1.
- Tumor necrosis factor (TNF).
- Effect of colony stimulating factor on murine macrophages. Induction of antitumor activity.
- Stimulation of macrophage antibody-dependent killing of tumor targets by recombinant lymphokine factors and M-CSF.
- Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages.
- Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity.
- Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay.
- Protective effect of partially purified human urinary colony-stimulating factor on granulocytopenia after antitumor chemotherapy.
- Recombinant and native human urinary colony-stimulating factor directly augments granulocytic and granulocyte-macrophage colony-stimulating factor production of human peripheral blood monocytes.
Cited by
- Transformation of rat glioma cells with the M-CSF gene inhibits tumorigenesis in vivo
- Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10.
- Vaccinia virus binding and infection of primary human leukocytes
- Macrophages can recognize and kill tumor cells bearing the membrane isoform of macrophage colony-stimulating factor.
- Rapid priming of human monocytes by human hematopoietic growth factors: granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists.
- Macrophages kill T9 glioma tumor cells bearing the membrane isoform of macrophage colony stimulating factor through a phagocytosis-dependent pathway.
- Immunomodulation by colony-stimulating factors.
- Effect of interleukin-3 and granulocyte-macrophage colony-stimulating factor on growth of xenotransplanted human tumour cell lines in nude mice.
- Tumoricidal effect of human macrophage-colony-stimulating factor against human-ovarian-carcinoma-bearing athymic mice and its therapeutic effect when combined with cisplatin
- Antitumor Immunity Induced by Irradiated Tumor Cells Producing Macrophage Colony-Stimulating Factor
- Influence of aging and chemoradiotherapy on leucocyte function in oral cancer patients.
- A tumor cell line producing granulocyte colony-stimulating factor and an immune suppressive factor
- Effects of macrophage colony-stimulating factor and interleukin-2 administration on NK1.1(+) cells in mice.
- Antitumor effects of human recombinant macrophage colony-stimulating factor against rat brain tumors
- Augmentation of Cancer Chemotherapy by Preinjection of Human Macrophage Colony‐stimulating Factor in L1210 Leukemic Cell‐inoculated Mice
- Human MCF activates monocytes to produce IL-1 but not TNF or CSF-1.
- Quantitative analysis of the two macrophage colony-stimulating factor mRNA expressed in a human stromal cell line by reverse transcription-polymerase chain reaction (RT-PCR).
- Granulocyte colony‐stimulating factor administration modulates the surface expression of effector cell molecules on human monocytes
- Effects of human interleukin 3, macrophage and granulocyte-macrophage colony-stimulating factor on monocyte function following autologous bone marrow transplantation.
- Leukemic Cell Lysis by Activated Human Macrophages: Significance of Membrane‐associated Tumor Necrosis Factor
Related papers
- Differentiation of human leukemic cell lines (HL60, U937) toward macrophages is accompanied by production of colony-stimulating activity (CSA).
- Substance P augments tumor necrosis factor release in human monocyte-derived macrophages.
- The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell lines.
- Usefulness of Monocytes/macrophages Activated With Low-dose Lipopolysaccharide in Tumor Tissue and Adipose Tissue of Obesity
- Downregulation of Tumor Necrosis Factor Expression in the Human Mono‐Mac‐6 Cell Line by Lipopolysaccharide
- C-reactive protein-induced colony-stimulating factors production by macrophages.